Viewing data from:

NICARDIPINE HYDROCHLORIDE

ANDA

NICARDIPINE HYDROCHLORIDE | A217555 | BIONPHARMA INC

2 strengths0 unique patents0 unique exclusivities

API Supply Chain13 active DMFs3 inactive

12 active API suppliers hold Drug Master Files for this ingredient.

LUSOCHIMICA SPANICARDIPINE HYDROCHLORIDE

DMF 94931992

OLON SPANICARDIPINE HYDROCHLORIDE

DMF 101041993

NAVINTA LLCNICARDIPINE HYDROCHLORIDE USP

DMF 197732006

WOCKHARDT LTDNICARDIPINE HYDROCHLORIDE

DMF 212112007

LUSOCHIMICA SPANICARDIPINE HYDROCHLORIDE (INTENDED FOR PARENTERAL USE)

DMF 216252008

HIKMA PHARMACEUTICALSNICARDIPINE HYDROCHLORIDE

DMF 232802009

GLAND PHARMA LTDNICARDIPINE HYDROCHLORIDE USP

DMF 291982015

SICHUAN QINGMU PHARMACEUTICAL CO LTDNICARDIPINE HYDROCHLORIDE

DMF 372872022

MSN LABORATORIES PRIVATE LTDNICARDIPINE HYDROCHLORIDE USP

DMF 375822023

QILU PHARMACEUTICAL CO LTDNICARDIPINE HYDROCHLORIDE USP

DMF 388762023

ZHEJIANG HUAHAI PHARMACEUTICAL CO LTDNICARDIPINE HYDROCHLORIDE USP

DMF 393262024

MAHI DRUGS PRIVATE LTDNICARDIPINE HYDROCHLORIDE USP

DMF 400132025

METROCHEM API PRIVATE LTDNICARDIPINE HYDROCHLORIDE USP

DMF 402352024

MAPRIMED SAInactiveNICARDIPINE HYDROCHLORIDE

DMF 89191991

MITSUBISHI CORPInactiveNICARDIPINE HYDROCHLORIDE

DMF 107021994

DR REDDYS LABORATORIES LTDInactiveNICARDIPINE HYDROCHLORIDE

DMF 220442008

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 20MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: May 3, 2023

No patent or exclusivity listings for this strength.

#002 — 30MG

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: May 3, 2023